INNO.CN CNQ
InnoCan Pharma Corporation
1W: -7.6%
1M: +1.4%
3M: -17.9%
YTD: -69.4%
1Y: -84.6%
3Y: -84.6%
5Y: -93.2%
C$2.20 ($1.54)
-0.15 (-6.38%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#11
of 30
Medical - Pharmaceuticals
Technical Signal Map
4 Bullish
0 Neutral
9 Bearish
INNO.CN
$10M
InnoCan Pharma Corporation
LEAN BEAR
-25
EBM.V
$130M
Eastwood Bio-Medical Canada Inc.
BULLISH
+84
CSCI.TO
$10M
COSCIENS Biopharma Inc.
BULLISH
+75
RX.V
$190M
BioSyent Inc.
BULLISH
+65
HITI
$330M
High Tide Inc.
BULLISH
+40
CYBN.NE
$410M
Cybin Inc.
LEAN BEAR
-27
PKBFF
$540M
PeakBirch Commerce Inc.
BEARISH
-32
MDP.TO
$160M
Medexus Pharmaceuticals Inc.
BEARISH
-59
GSD.V
$20M
Devonian Health Group, Inc.
BEARISH
-75
HELP
$740M
Cybin Inc. Common Stock
BEARISH
-80
MYCOF
$40M
Noveris Health Sciences Inc.
BEARISH
-91
LSL.V
$40M
LSL Pharma Group Inc
BEARISH
-91
INNPF
$10M
INNOCAN PHARMA Corp
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| INNO.CN InnoCan Pharma Corporation | $10M | -7.4 | -20.9 | -13549.9 | -0.6 | -18.6 | 3 | LEAN BEAR | -84.6 |
| EBM.V Eastwood Bio-Medical Canada Inc. | $130M | -645.2 | 13.9 | 12.4 | -45.1 | 36.6 | 6 | BULLISH | 380.5 |
| CSCI.TO COSCIENS Biopharma Inc. | $10M | — | — | — | — | — | — | BULLISH | — |
| RX.V BioSyent Inc. | $190M | 19.0 | 23.7 | 23.8 | 14.3 | 40.9 | 4 | BULLISH | 41.1 |
| HITI High Tide Inc. | $330M | -9.9 | -26.9 | 1.6 | 5.7 | 27.2 | 3 | BULLISH | -27.1 |
| CYBN.NE Cybin Inc. | $410M | -2.8 | -62.5 | -156.6 | — | — | 2 | LEAN BEAR | 73.8 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| MDP.TO Medexus Pharmaceuticals Inc. | $160M | -43.4 | -4.7 | 6.8 | -10.9 | -8.3 | 5 | BEARISH | 67.0 |
| GSD.V Devonian Health Group, Inc. | $20M | — | — | — | — | — | — | BEARISH | — |
| HELP Cybin Inc. Common Stock | $740M | -2.8 | -38.6 | -94.5 | — | — | 2 | BEARISH | — |
| MYCOF Noveris Health Sciences Inc. | $40M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 12066.7 |
| LSL.V LSL Pharma Group Inc | $40M | — | — | — | — | — | — | BEARISH | — |
| INNPF INNOCAN PHARMA Corp | $10M | -7.4 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -80.8 |
| INNO.CN InnoCan Pharma Corporation | $10M | -7.4 | -20.9 | -13549.9 | -0.6 | -18.6 | 3 | LEAN BEAR | -84.6 |
| EBM.V Eastwood Bio-Medical Canada Inc. | $130M | -645.2 | 13.9 | 12.4 | -45.1 | 36.6 | 6 | BULLISH | 380.5 |
| CSCI.TO COSCIENS Biopharma Inc. | $10M | — | — | — | — | — | — | BULLISH | — |
| RX.V BioSyent Inc. | $190M | 19.0 | 23.7 | 23.8 | 14.3 | 40.9 | 4 | BULLISH | 41.1 |
| HITI High Tide Inc. | $330M | -9.9 | -26.9 | 1.6 | 5.7 | 27.2 | 3 | BULLISH | -27.1 |
| CYBN.NE Cybin Inc. | $410M | -2.8 | -62.5 | -156.6 | — | — | 2 | LEAN BEAR | 73.8 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| MDP.TO Medexus Pharmaceuticals Inc. | $160M | -43.4 | -4.7 | 6.8 | -10.9 | -8.3 | 5 | BEARISH | 67.0 |
| GSD.V Devonian Health Group, Inc. | $20M | — | — | — | — | — | — | BEARISH | — |
| HELP Cybin Inc. Common Stock | $740M | -2.8 | -38.6 | -94.5 | — | — | 2 | BEARISH | — |
| MYCOF Noveris Health Sciences Inc. | $40M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 12066.7 |
| LSL.V LSL Pharma Group Inc | $40M | — | — | — | — | — | — | BEARISH | — |
| INNPF INNOCAN PHARMA Corp | $10M | -7.4 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -80.8 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
INNO.CN vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F